Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Events

December 1, 2016

IP Counsel Exchange

Barclay Damon, LLP, Partner, Denis J. Sullivan will present "PTAB Litigation Crash Course: A Litigator's Guide to Obtaining Successful Results at the PTAB" on December 1, 2016 at the IP Counsel Exchange in New York City.

Once engaged in a proceeding at the PTAB counsel must be sure to make note of the venue's nuanced proceedings. As opposed to federal district court in which experts are permitted to provide live testimony, the procedure for utilizing experts and presenting witnesses in IPRs and other PTAB proceedings is notably different. As such and in order to ensure that key facts are brought to life and the theory of your case is best set out, it is crucial to a successful outcome that you ensure your experts and witnesses are best positioned in depositions and testimony. During this session –

  • Gain insights into the best uses of, timing for and initiation of various types of PTAB proceedings
  • Strategies for responding to single vs. multiple IPRs
  • Learn how to most effectively utilize experts, present witnesses and evidence in PTAB proceedings – scientists, investors, in-house vs. external experts
  • Understand the impact PTAB proceedings are having IP litigation ongoing in other venues and how your litigation team should plan adjust your PTAB litigation strategy based on parallel or co-pending litigation in alternate forums (i.e., Federal District Court, ITC, international venues)

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks